We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+1.21%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$1.19B
AUM Growth
+$49.5M
Cap. Flow
+$37.2M
Cap. Flow %
3.14%
Top 10 Hldgs %
70.04%
Holding
247
New
15
Increased
82
Reduced
97
Closed
10

Sector Composition

Rank Sector Weight
1 Industrials 1.95%
2 Consumer Discretionary 1.88%
3 Healthcare 1.47%
4 Technology 1.41%
5 Financials 1.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
101
Accenture
ACN
$86.1B
$527K 0.04%
4,653
+129
+3% +$15K
NKE icon
102
Nike
NKE
$63.9B
$525K 0.04%
9,536
-249
-3% -$14.2K
WBA
103
DELISTED
Walgreens Boots Alliance
WBA
$520K 0.04%
6,251
-1,421
-19% -$115K
ESRX
104
DELISTED
Express Scripts Holding Company
ESRX
$520K 0.04%
6,856
+26
+0.4% +$1.91K
BNY
105
Bank of New York Mellon
BNY
$108B
$512K 0.04%
13,152
+267
+2% +$10.6K
QQQ icon
106
Invesco QQQ Trust
QQQ
$466B
$512K 0.04%
4,763
SLB icon
107
SLB Ltd
SLB
$70B
$500K 0.04%
6,304
+781
+14% +$59.9K
AMGN icon
108
Amgen
AMGN
$197B
$494K 0.04%
3,248
+34
+1% +$5.29K
Y
109
DELISTED
Alleghany Corp
Y
$493K 0.04%
896
-29
-3% -$15.1K
SDY icon
110
State Street SPDR S&P Dividend ETF
SDY
$21.7B
$489K 0.04%
5,825
-760
-12% -$61.8K
ABBV icon
111
AbbVie
ABBV
$449B
$486K 0.04%
7,853
+663
+9% +$40.4K
TGT icon
112
Target
TGT
$63.8B
$485K 0.04%
6,927
+620
+10% +$46.3K
CELG
113
DELISTED
Celgene Corp
CELG
$483K 0.04%
4,892
-135
-3% -$14K
VOO icon
114
Vanguard S&P 500 ETF
VOO
$976B
$482K 0.04%
2,509
TD icon
115
Toronto Dominion Bank
TD
$200B
$480K 0.04%
11,187
+16
+0.1% +$696
BIIB icon
116
Biogen
BIIB
$29.8B
$476K 0.04%
1,965
+154
+9% +$40.6K
VUG icon
117
Vanguard Growth ETF
VUG
$222B
$465K 0.04%
26,040
USB icon
118
US Bancorp
USB
$98.4B
$459K 0.04%
11,355
+137
+1% +$5.7K
DHR icon
119
Danaher
DHR
$144B
$457K 0.04%
6,704
+204
+3% +$13.3K
UNP icon
120
Union Pacific
UNP
$179B
$450K 0.04%
5,164
-1
-0% -$85
SAN icon
121
Banco Santander
SAN
$192B
$442K 0.04%
117,581
+49
+0% +$213
NVO
122
Novo Nordisk
NVO
$222B
$425K 0.04%
15,818
+284
+2% +$7.79K
GSK icon
123
GSK
GSK
$102B
$423K 0.04%
7,802
-820
-10% -$43.2K
ADI icon
124
Analog Devices
ADI
$185B
$420K 0.04%
7,424
-272
-4% -$15.6K
NVS icon
125
Novartis
NVS
$290B
$417K 0.04%
5,642
+643
+13% +$44.4K

Similar funds

Ballentine Partners's Q2 2016 Portfolio in Review

As of Q2 2016, Ballentine Partners held 247 positions worth $1.19B, up 4.4% from $1.14B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Ballentine Partners deployed $37.2M of net new capital in Q2 2016, opening 15 new positions and adding to 82 existing holdings. Its largest new stake was LKQ Corp: 354,618 shares worth $11.2M.

By sector, the portfolio is most concentrated in Industrials at 2% of assets, down from 2.1% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $4.63M trimmed.

  • Ballentine Partners's largest Q2 2016 buy was LKQ Corp: 354,618 shares worth $11.2M.
  • Ballentine Partners added most to Vanguard Total Stock Market ETF in Q2 2016, an estimated $19.8M increase.
  • Ballentine Partners's biggest Q2 2016 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $4.63M.
  • Ballentine Partners fully exited Endurance International Group Holdings, Inc. in Q2 2016, selling an estimated $4.66M.
  • Ballentine Partners's ten largest holdings make up 70% of its $1.19B portfolio in Q2 2016.
  • Ballentine Partners opened 15 new positions and closed 10 in Q2 2016.
  • Ballentine Partners's portfolio value rose 4.4% quarter-over-quarter to $1.19B.

Based on Ballentine Partners's 13F filing for Q2 2016, filed 3 Aug 2016.